BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34400878)

  • 1. Relationship between the Metabolic Associated Fatty Liver Disease and Endometrial Thickness in Postmenopausal Women: A Cross-sectional Study in China.
    Wei JY; Xu Z; Li H; Du WQ; Niu BL; Li S; Tian S; Wu J; Chen YL; Li X; Liu ZL; Xiao J; Ren GS; Ran L; Kong LQ
    Int J Med Sci; 2021; 18(14):3082-3089. PubMed ID: 34400878
    [No Abstract]   [Full Text] [Related]  

  • 2. An Observational and Cross-Sectional Study of the Prevalence of Breast Lesions and Metabolic Dysfunction-Associated Fatty Liver Disease and their Relationship in China.
    Li S; Xu Z; Li H; Tang J; Liang XY; Tian S; Wu J; Li X; Liu ZL; Xiao J; Chen YL; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    J Gastrointestin Liver Dis; 2022 Mar; 31(1):31-39. PubMed ID: 35306559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
    Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of the relationship between endometrial thickness and prevalence of breast mass in postmenopausal women.
    Li H; Ran L; Wu H; Xu Z; Wu KN; Kong LQ
    Int J Gynaecol Obstet; 2019 Jun; 145(3):306-311. PubMed ID: 30927444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.
    Guo Y; Hu Y; Yang J; Ma R; Zhang X; Guo H; Wang X; Li Y; Peng X; Zhang S; He J; Guo S
    Eur J Med Res; 2023 Dec; 28(1):555. PubMed ID: 38042816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.
    Liu D; Shen Y; Zhang R; Xun J; Wang J; Liu L; Steinhart C; Chen J; Lu H
    J Gastroenterol Hepatol; 2021 Jun; 36(6):1670-1678. PubMed ID: 33140878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China.
    Chang M; Shao Z; Wei W; Shen P; Shen G
    Front Endocrinol (Lausanne); 2023; 14():1241169. PubMed ID: 37822594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and predicting factors of metabolic-associated fatty liver disease diagnosed by transient elastography with controlled attenuation parameters in HIV-positive people.
    Jongraksak T; Sobhonslidsuk A; Jatchavala J; Warodomwichit D; Kaewduang P; Sungkanuparph S
    Int J STD AIDS; 2021 Mar; 32(3):266-275. PubMed ID: 33334267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
    Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
    J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study.
    Huang YP; Zhang S; Zhang M; Wang Y; Wang WH; Li J; Li C; Lin JN
    BMJ Open; 2021 Dec; 11(12):e056260. PubMed ID: 34911725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between nonalcoholic fatty liver and increased low-level albuminuria in postmenopausal women in China: A cross-sectional study.
    Su W; Wang Y; Chen K; Wang J; Wang A; Tang X; Yan L; Luo Z; Qin G; Chen L; Ning G; Mu Y
    J Diabetes; 2021 Jun; 13(6):494-505. PubMed ID: 33200507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The progression and regression of metabolic dysfunction-associated fatty liver disease are associated with the development of subclinical atherosclerosis: A prospective analysis.
    Liu S; Wang J; Wu S; Niu J; Zheng R; Bie L; Xin Z; Wang S; Lin H; Zhao Z; Wang T; Xu M; Lu J; Chen Y; Xu Y; Wang W; Ning G; Bi Y; Li M; Xu Y
    Metabolism; 2021 Jul; 120():154779. PubMed ID: 33895182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic dysfunction-associated fatty liver disease increased the risk of subclinical carotid atherosclerosis in China.
    Lei F; Wang XM; Wang C; Huang X; Liu YM; Qin JJ; Zhang P; Ji YX; She ZG; Cai J; Li HP; Zhang XJ; Li H
    Front Endocrinol (Lausanne); 2023; 14():1109673. PubMed ID: 37082131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ability to successfully image endometrium on transvaginal ultrasound in asymptomatic postmenopausal women.
    Goldstein SR; Khafaga A
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):625-629. PubMed ID: 33998081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between complement C3 and the prevalence of metabolic-associated fatty liver disease in a Chinese population: a cross-sectional study.
    Feng L; Zhao Y; Wang WL
    BMJ Open; 2021 Oct; 11(10):e051218. PubMed ID: 34711595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thickened endometrium in asymptomatic postmenopausal women - determining an optimum threshold for prediction of atypical hyperplasia and cancer.
    Ghoubara A; Emovon E; Sundar S; Ewies A
    J Obstet Gynaecol; 2018 Nov; 38(8):1146-1149. PubMed ID: 29862866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAFLD and risk of CKD.
    Sun DQ; Jin Y; Wang TY; Zheng KI; Rios RS; Zhang HY; Targher G; Byrne CD; Yuan WJ; Zheng MH
    Metabolism; 2021 Feb; 115():154433. PubMed ID: 33212070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of sonography for detecting endometrial pathologies in postmenopausal women with and without bleeding.
    Seckin B; Cicek MN; Dikmen AU; Bostancı EI; Muftuoglu KH
    J Clin Ultrasound; 2016 Jul; 44(6):339-46. PubMed ID: 26857098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age at menarche and metabolic dysfunction-associated fatty liver disease: Evidence from a large population-based epidemiological study in Southwest China.
    Li K; Yin J; Qin Z; Ma B; He R; Zhuoma D; Wang Z; Liu Q; Zhao X
    Prev Med; 2023 Dec; 177():107776. PubMed ID: 37951543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.